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Abstract
Introduction: Sarcoidosis is a multisystem granulomatous disease for which the association with mycobacteria
continues to strengthen. It is hypothesized that a single, poorly degradable antigen is responsible for sarcoidosis
pathogenesis. Several reports from independent groups support mycobacterial antigens having a role in sarcoidosis
pathogenesis. To identify other microbial targets of the adaptive immune response, we tested the ability of CD4+
and CD8+ T cells to recognize multiple mycobacterial antigens.
Methods: Fifty-four subjects were enrolled in this study: 31 sarcoidosis patients, nine non-tuberculosis
mycobacterial (NTM) infection controls, and 14 PPD- controls. Using flow cytometry, we assessed for Th1 immune
responses to ESAT-6, katG, Ag85A, sodA, and HSP.
Results: Alveolar T-cells from twenty-two of the 31 sarcoidosis patients produced a CD4+ response to at least one
of ESAT-6, katG, Ag85A, sodA, or HSP, compared to two of 14 PPD- controls (p = 0.0008) and five of nine NTM
controls (p = 0.44), while eighteen of the 31 sarcoidosis subjects tested produced a CD8+ response to at least one
of the mycobacterial antigens compared to two of 14 PPD- controls (p = 0.009) and three of nine NTM controls
(0.26). Not only did the BAL-derived T cells respond to multiple virulence factors, but also to multiple, distinct
epitopes within a given protein. The detection of proliferation upon stimulation with the mycobacterial virulence
factors demonstrates that these responses are initiated by antigen specific recognition.
Conclusions: Together these results reveal that antigen-specific CD4+ and CD8+ T cells responses to multiple
mycobacterial epitopes are present within sites of active sarcoidosis involvement, and that these antigen-specific
responses are present at the time of diagnosis.
Introduction
Sarcoidosis is a granulomatous disease of unknown
etiology, characterized by a Th1 immunophenotype.
Immunological studies have shown that there are oligo-
clonal T cells in sarcoid bronchoalveolar lavage (BAL),
suggesting that the response is antigen-specific [1,2].
Investigation into T cell receptors in BAL fluid has
shown an AV2S3+ T cell expansion in the lung of sar-
coidosis patients with HLA-DRB1*0301 and HLA-
DRB3*0101 also supporting an antigen specific response
in the sarcoid lung [3]. Multiple studies have shown an
association between mycobacterial antigens and sarcoi-
dosis. Song et al. found mycobacterial katG in sarcoido-
sis granulomas using both mass spectrometry and
immunohistochemistry [4]. In addition, mycobacterial
DNA has been found in sarcoid granulomas [5,6]. Stu-
dies have also shown T cell Interferon-g (IFN-g)p r o d u -
cing responses to mycobacterial peptides in both
peripheral blood mononuclear cells [7-12] and bronch-
oalveolar lavage fluid [9,13].
It has been suggested that sarcoidosis is a hypersensitiv-
ity reaction caused by prolonged exposure to a specific
antigen [9]. However, we have shown in a previous study
that in peripheral blood mononuclear cells, multiple
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T cells from sarcoidosis BAL can produce an IFN-g
response to both mycobacterial ESAT-6 and KatG [14].
The purpose of this study is to assess if responses to
multiple mycobacterial virulence factors are present in
an active site of sarcoidosis involvement at the time of
diagnosis. We investigated for immune response to
actively secreted mycobacterial virulence factors that
had previously been shown to elicit Th-1 immune
responses [14]. We analyzed specific responses to myco-
bacterial early secreted antigenic target protein 6
(ESAT-6), catalase-peroxidase (katG), mycolyl transfer-
ase (Ag85A), superoxide dismutase A (sodA), and heat
shock protein 70 (HSP) in BAL derived T cells.
Materials and methods
Study subjects
The study participants were recruited from The Cleveland
Clinic (Cleveland, OH) and Vanderbilt University Medical
Center (Nashville, TN). We prospectively enrolled patients
who were undergoing bronchoscopy where sarcoidosis
was a diagnostic consideration (Table 1). All subjects pro-
vided written informed consent that was approved by the
appropriate Institutional Review Boards. Fifty-four patients
were enrolled in this study: 31 sarcoidosis subjects, 14 dis-
ease controls with a negative purified protein derivative
(PPD-) test, and 9 subjects with a nontuberculosis myco-
bacterial infection (NTM) such as Mycobacterium avium
(Table 1, Additional File 1, Table S1). The PPD- disease
controls were subjects with clinical syndromes consistent
with sarcoidosis for which an alternative diagnosis was
obtained such as Aspergillosis, fungal infection, lym-
phoma, lung cancer and pneumonia. None of these
patients were diagnosed with fungal infection. Demo-
graphic characteristics of these patient groups are listed in
Table 1 and Additional File1, Table S1. For the sarcoidosis
subjects who underwent tuberculin skin testing at the
discretion of their physician, all were skin test negative,
and none have developed mycobacterial infection since
the time of their bronchoscopy. Kruskal-Wallis analysis
indicated there was a significant difference in age distribu-
tions across patient groups (p < 0.001; Table 1); a Pearson
test performed across patient groups indicated no differ-
ence according to race or sex (Table 1; bi-racial subjects
were omitted from the race analysis).
The subjects had their chest radiographs or chest
computer tomography scans staged according to the
method described by Scadding [15]: stage 0: no infil-
trates or adenopathy,; stage 1: hilar adenopathy alone;
stage 2: adenopathy plus infiltrates; stage 3: infiltrates
alone; stage 4: fibrosis. Unlike the traditional Scadding
system, these determinations were made by viewing the
chest CT scan when one was available. Otherwise, the
chest radiograph was used to perform this staging.
Histopathological diagnosis of sarcoidosis was con-
firmed by a pathologist (i.e. specimens from each patient
had confluent non-caseating granulomas, with negative
cultures and stains for bacteria, fungi and acid-fast
bacilli), and no history of exposure to antigens known
to cause granulomatous lung disease. Disease controls
were subjects for whom an alternate diagnosis was
obtained after bronchoscopy.
BAL isolation and culture
BAL fluid was obtained from diagnostic bronchoscopy
and centrifuged at 1500 rpm for 15 minutes. The BAL
cell pellet was washed with RPMI 1640 supplemented
medium. BAL cells were either stored in liquid nitrogen
in freezing media for future analysis or analyzed imme-
diately. The media used in all experiments was RPMI
1640 (Cellgro) supplemented with 10% FBS (Gemini
Bio-Products), penicillin (50 U/ml; Cellgro), streptomy-
cin (50 μg/ml; Cellgro), sodium pyruvate (1 mM; cell-
gro), and glutamine (2 mM; Cellgro). Freezing media
Table 1 Demographics of study population
Characteristics Sarcoidosis PPD- NTM p value
Number 31 14 9 NS
Sex, female/male 19/12 11/3 5/4 NS
Age (yr), median (min, max) 47 (25,64) 49 (24,61) 67 (51,75) NS
Race 8AA:22C:1H/AA 3AA:10C:1A/S 1AA:8C NS
Stage 0/I/II/III/IV 1/12/17/1/0 ND ND
IS at Bronch 12/19 ND ND
Lym (%), median (min, max) 15 (1, 59) 7 (1, 37) 14 (3, 66)
Extrapulmonary disease, yes/no 7/24 ND ND
Smoking status 3AS:11EX:17NS 1AS:5EX:8NS 1AS:5EX:3NS
CD4/CD8 ratio, median (min,max) 2.87 (0.56,70.54) 1.30 (0.14,36.57) 2.95 (0.49,9.1)
Definition of abbreviations: NTM = non-Tuberculosis mycobacterial infection; NS = not significant, yr = years, min = minimum, max = maximum, ND = not done,
A = Asian, AA = African American, C = Caucasian, H = Hispanic, S = Samoan; IS = immunosuppressant; Lym = lymphocyte; AS = active smoker; EX = ex-smoker;
NS = never smoker. Statistical differences were assessed using the Wilcoxon rank sum test. The p values listed are for the comparison between sarcoidosis and
PPD-. No significant difference was seen between sarcoidosis and NTM groups.
Oswald-Richter et al. Respiratory Research 2010, 11:161
http://respiratory-research.com/content/11/1/161
Page 2 of 11consisted of 50% RPMI 1640 supplemented medium,
40% FBS, and 10% DMSO.
Synthesis of Mycobacterium peptides
The two ESAT-6, two KatG, four Antigen 85A (Ag85A)
peptides, and four SodA peptides were synthesized as
described previously (Table 2) [16]. Each peptide was
synthesized by solid-phase F-moc chemistry (Genemed
Synthesis, San Diego, CA, USA), to a purity of > 70%.
Identity was confirmed by mass spectroscopy, and the
purity was assessed by high performance liquid chroma-
tography. We acquired Ag85A whole protein from Col-
orado State University through National Institutes of
Health (NIH) Contract HHSN266200400091c, “TB vac-
cine testing and research materials.” Isolation of MTB
Ag85A from cell culture was performed as previously
described [17]. Heat shock protein was provided as a
kind gift from Doug Kernodle (Vanderbilt University).
Due to limitations in cell numbers within the BAL, not
all antigens were tested for each subject. The antigens
were prioritized in the following order: ESAT-6, KatG,
Ag85A, sodA and HSP.
Flow cytometry analysis - cytokine and
proliferation assays
Intracellular staining was performed in order to identify
IFN-g secreting T cells in response to microbial stimula-
tion. For the intracellular cytokine assay, 1-2×10
5 BAL
cells were incubated in RPMI 1640 supplemented medium
with or without antigen (ESAT-6, KatG, Ag85A, sodA or
HSP peptides; 20 μg/ml) or staphylococcal enterotoxin B
(SEB; 10 μg/ml; Sigma) as positive control and the anti-
CD28 and anti-CD49d antibodies (1 μg/ml each; BD Bios-
ciences) at 37°C under 5% CO2 for 1 hour before addition
of BD GolgiStop (BD Biosciences). In addition, to assess
for nonspecific recognition, neoantigen, Keyhole Limpet
Hemocyanin (KLH; 10 μg/ml; Calbiochem) was included
as an additional negative control. Following a 6 hour incu-
bation at 37°C under 5% CO2, cells were washed and
stained with the surface antibodies anti-CD3, anti-CD4,
and anti-CD8 (BD Biosciences) at 4°C for 30 minutes.
After washing, fixation, and permeabilization, using a Fix
& Perm Kit according to the manufacturer’s instructions
(BD Biosciences), anti-IFN-g and anti-IL-2 (BD Bios-
ciences) were added at 4°C for 45 minutes. Cells were
washed and analyzed via flow cytometry. The IFN-g and
IL-2 frequencies were defined as the subject’s percentage
of stimulated CD3+CD4+ or CD3+CD8+ T cells minus
their unstimulated background frequency. Based upon
previous studies, a response was considered positive when
the frequency of recognition was at least twice background
fluorescence and greater than 0.5% [18-20].
To determine proliferation and quantitate cell division,
purified BAL cells were labeled with carboxyfluorescein
succinimidyl ester (CFSE; Molecular Probes). Purified
cells were first washed and resuspended in PBS. While
vortexing the cells, CFSE was added at a final concentra-
tion of 5 μM. The mixture was vortexed for an addi-
tional 15 seconds and incubated at 37°C for 3 minutes.
Labeling was quenched by the addition of 50% FBS in
PBS. Cells were washed once more with 50% serum
PBS, followed by two washes with RPMI 1640-supple-
mented medium. CFSE-labeled BAL cells were stimu-
l a t e di nR P M I1 6 4 0s u p p l e m e n t e dm e d i u mw i t ho r
without peptide (20 μg/ml) or SEB as positive control.
All flow cytometry experiments were acquired with a
LSR-II flow cytometer (BD Biosciences). Live cells were
gated based on forward and side scatter properties and
analysis was performed using FlowJo software (Tree
Star). A minimum of 30,000 events were acquired per
sample.
Statistical analysis
Statistical analyses were performed using statistical pro-
gramming language R (version 2.8.1.). Association of a
positive detection of immune responses to one or more
mycobacterial virulence factors but not from other pul-
monary disease controls (i.e. yes/no) was determined by
using Fisher’s exact test due to anticipated small cell
counts. Differences in the distributions of immune recog-
nition of mycobacterial antigen by CD4+ and CD8+
T cells from BAL were tested across diagnosis groups
using the Wilcoxon rank sum test at an a-level of 0.05.
In addition, it is unclear whether each radiographic stage
of sarcoidosis reflects a different etiology or a distinct
immune response to the same antigen. Therefore, differ-
ences in the distribution of immune recognition in sar-
coidosis patients across two of four radiographic stages
were assessed using the Kruskal-Wallis rank sum test. All
tests of association were performed using an alpha-level
Table 2 Peptide Sequence
Peptide Sequence
Esat-6 14 NNALQNLARTISEAG
15 NLARTISEAGQAMAS
KatG 31 WTNTPTKWDNSFLEI
32 TKWDNSFLEILYGYE
Ag85A Whole protein
a LQVPSPSMGRDIKVQFQSGG
b DWYQPACGKAGCQTYKWETL
3 DIKVQFQSGGANSPALYLLD
6 WDINTPAFEWYDQSGLSVVM
SodA 31 LGIVPLLLLDMWEHA
33 MWEHAFYLQYKNVKV
36 DFAKAFWNVVNWADV
38 NWADVQSRYAAATSQ
HSP70 Whole protein
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comparisons.
Results
Sarcoidosis BAL CD4+ T cells exhibit multiple recognition
of mycobacterial antigens
Twenty-two of the 31 sarcoidosis BAL samples produced
a CD4+ response to at least one of the mycobacterial epi-
topes of ESAT-6, KatG, Ag85A, sodA, or HSP, compared
to two of 14 PPD- controls (p = 0.00084) and five of nine
NTM controls (p = 0.437) (Figure 1A, B; Table 3). Nine-
teen of the 31 sarcoidosis patients responded to at least
one of the two ESAT6 peptides compared with two of 14
PPD- controls (p = 0.0042) and five of nine NTM con-
trols (p = 1.0). For the two katG peptides, 11 of 29 sarcoi-
dosis subjects, two of 14 PPD- subjects (p = 0.16) and
f o u ro fe i g h tN T Ms u b j e c t sr e s p o n d e dt oa tl e a s to n e
peptide (p = 0.68). Using four Ag85A peptides and
Ag85A whole protein, 10 of 22 sarcoidosis subjects, one
of 12 PPD- subjects (p = 0.053) and two of three NTM
subjects responded to at least one of the peptides and/or
whole protein (p = 0.59). Seven of 21 sarcoidosis subjects
responded to at least one of four sodA peptides, com-
pared with one of nine PPD- subjects (p = 0.37) and
none of three NTM subjects (p = 0.53). Four of 17 sarcoi-
dosis subjects responded to HSP, compared with one of
seven PPD- subjects (p = 1) and one of three NTM sub-
jects (p = 1).
When compared to PPD
- controls, there was a signifi-
cant difference in the distribution of the sarcoidosis Th-1
immune response against ESAT-6 (p = 0.004, Wilcoxon),
katG (p = 0.06, Wilcoxon), and Ag85A (p = 0.014,
Wilcoxon) (Figure 2). Although sarcoidosis BAL-derived
T cells produced more IFN-g in response to sodA, there
Figure 1 Sarcoidosis CD4+ Th1 responses in BAL to multiple mycobacterial antigens. BAL from sarcoidosis subjects, PPD- diseased controls
and non-Tuberculosis Mycobacterial (NTM) infection subjects were stimulated with neoantigen (KLH), ESAT-6, katG, Ag85A, sodA, HSP and SEB
(positive control), then intracellular cytokine staining for IFN-g was performed. (A) Gating strategy and representative flow data for CD4+ T cell
IFN-g responses. (B) The number of Sarcoidosis, PPD- and NTM subjects that did (red) or did not (blue) respond to stimulation with mycobacteria
peptides. CD4+ T cell response was defined as positive when the frequency of recognition was at least twice background fluorescence and
greater than 0.5%.
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Upon stimulation with mycobacterial HSP, sarcoid BAL-
derived T cells did not produce more IFN-g than PPD
-
controls.
Sarcoidosis BAL-derived CD8+ T cells recognize multiple
mycobacterial antigens
Eighteen of the 31 sarcoidosis subjects produced a CD8
+ response to at least one of the mycobacterial virulence
factors: ESAT-6, KatG, Ag85A, sodA, or HSP, compared
to two of 14 PPD- controls (p = .009) and three of nine
NTM controls (Figure 3A,B; Additional File 1, Table S1)
(p = 0.26). Seventeen of 31 sarcoidosis subjects
responded to ESAT-6 peptides compared with two of 14
PPD- subjects (p = 0.021), and three of nine NTM sub-
jects (p = 0.45). CD8+ T cells produced IFN-g in
response to katG in 8 of 29 sarcoidosis subjects, two of
14 PPD- subjects (p = 0.46) and three of eight NTM
subjects (p = 0.67). Nine of 22 sarcoidosis subjects
recognized at least of the four Ag85A peptides or whole
protein, compared to two of 12 PPD- subjects (p = 0.14)
and one of three NTM subjects (p = 1.0). Of the four
Table 3 CD4+ and CD8+ T cell response to mycobacterial virulence factors
Sarcoidosis PPD- NTM P-value
Total Subjects 31 14 9
CD4+ Response to any mycobacterial antigen 22 2 5 0.0008*
CD4+ Response to multiple mycobacterial antigens 16 2 4 0.02*
CD8+ Response to any mycobacterial antigen 18 2 3 0.009*
CD8+ Response to multiple mycobacterial antigen 12 2 3 0.12*
*Comparison of Sarcoidosis to PPD- subjects by two-tailed, Fisher’s exact test. CD4+ or CD8+ response was defined as positive when the frequency of recognition
was at least twice background fluorescence and greater than 0.5%.
Figure 2 Sarcoidosis CD4+ BAL T cells produce IFN-g in response to multiple mycobacterial antigens. Percent CD4+ cells that produce
IFN-g after stimulation with neoantigen (KLH), ESAT-6, katG, Ag85A, sodA, and HSP. Differences in the CD4+ immune response across diagnosis
groups were noted using the Wilcoxon rank sum test. Medians are depicted by lines. Stimulation of BAL cells with SEB resulted in a positive
IFN-g response for sarcoidosis subjects and disease controls. The p values listed are for the comparison between sarcoidosis and PPD-. No
significant difference was seen between sarcoidosis and NTM group.
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responded compared to one of nine PPD- subjects (p =
0.20), and none of three NTM subjects (p = 0.53). Using
HSP, there was a response from 5 of 17 sarcoidosis
patients, one of seven PPD- patients (p = 0.63) and one
of three NTM patients. (p = 1.0). Of those who demon-
strated CD8+ IFN-g responses against mycobacterial
virulence factors, 13 of 31sarcoidosis versus two of
14 PPD- controls (p = 0.09) and three of nine NTM
controls (0.49) had responded to multiple antigens
(Figure 3B).
In regards to the distribution of the CD8+ T cell
response against mycobacterial virulence factors, IFN-g
immune responses against ESAT-6 (0.02, Wilcoxon) and
sodA (0.013, Wilcoxon) were significant between sarcoi-
dosis and PPD- subjects. The distribution of the
immune responses against Ag85A approached signifi-
cance among sarcoidosis and PPD- (0.069, Wilcoxon).
There was no significant difference between these two
groups in response to katG or HSP (Figure 4).
Individual sarcoidosis subjects recognize multiple distinct
mycobacterial epitopes
The five mycobacterial virulence factors chosen for
T cell stimulation demonstrated no similarity in peptide
sequence (Table 2). Despite this lack of homology in
position identity among the mycobacterial peptides, 16
sarcoidosis subjects, two PPD- controls and four NTM
controls demonstrated CD4+ T cell responses to multi-
ple antigens (Figure 5). Sarcoidosis 4 and Sarcoidosis 24
responded to all five antigens, demonstrating distinc-
tions in the magnitude of the response to individual
peptides (Figure 5). No single antigen was recognized by
all sarcoidosis subjects. If one considers the 22 patients
that demonstrated an immune responses to any myco-
bacterial antigen, 20 responded to ESAT-6; only two of
Figure 3 Sarcoidosis CD8+ Th1 responses in BAL to multiple mycobacterial antigens. BAL from sarcoidosis subjects, PPD- diseased controls
and non-Tuberculosis Mycobacterial (NTM) infection subjects were stimulated with neoantigen (KLH), ESAT-6, katG, Ag85A, sodA, HSP and SEB
(positive control), then intracellular cytokine staining for IFN-g was performed. (A) Gating strategy and representative flow data for CD8+ T cell
IFN-g responses. (B) The number of Sarcoidosis, PPD- and NTM subjects that did (red) or did not (blue) respond to stimulation with mycobacteria
peptides. CD8+ T cell response was defined as positive when the frequency of recognition was at least twice background fluorescence and
greater than 0.5%.
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the six subjects recognizing only one mycobacterial viru-
lence factor, five responded to ESAT-6 and one to KatG.
PPD- 11 was the lone subject with pneumonia who
demonstrated strong responses against ESAT-6, KatG,
Ag85A and HSP (data not shown).
Of those sarcoidosis subjects demonstrating CD8+
T cell responses to multiple antigens, Sarcoidosis 4, 8
and 24 responded to all five antigens, despite the fact
that these peptides were not structurally similar (data
not shown). No single antigen was recognized by every
subject who demonstrated multiple responses. The
majority of sarcoidosis subjects did respond to ESAT-6;
only one of 13 multiple responders did not respond to
ESAT-6. All five single responders demonstrated IFN-g
immune responses when stimulated by ESAT-6.
Sarcoidosis BAL cells proliferate in response to
mycobacterial antigen
In chronic inflammatory states, non-specific recognition
can induce cytokine production. Although the lack of
recognition of KLH and the detection of immune
responses to mycobacterial antigens suggested that the
recognition observed was antigen-specific, we tested the
ability of the BAL-derived T cells to proliferate in
response to each of the five mycobacterial virulence fac-
tors. BAL cells were labeled with carboxyfluorescein suc-
cinimidyl ester (CFSE), a fluorescent dye used to monitor
the number of cell divisions, then stimulated with the
peptide or whole protein of interest on 5 sarcoidosis
patients. In Sarcoidosis 8, activation with ESAT-6, katG,
Ag85A, and sodA resulted in moderate proliferation of
the CD4+ and CD8+ T cells compared to no peptide or
KLH (neoantigen), while heat shock protein elicited low
level proliferation (Figure 6). This lack of proliferation to
heat shock protein was consistent with the lack of
immune recognition observed in Sarcoidosis 8. These
results, combined with the lack of recognition of KLH
(Figure 6), provide compelling evidence of antigen-speci-
fic recognition of multiple mycobacterial antigens in
diagnostic bronchoalveolar lavage, an active site of sar-
coidosis involvement. Evidence of proliferation upon sti-
mulation with mycobacterial antigens was also detected
in Sarcoidosis 4, 10 and 24 (data not shown).
Figure 4 Sarcoidosis CD8+ BAL T cells produce IFN-g in response to multiple mycobacterial antigens. Percent CD8+ cells that produce
IFN-g after stimulation with neoantigen (KLH), ESAT-6, katG, Ag85A, sodA, and HSP. Differences in the CD8+ immune response across diagnosis
groups were noted using the Wilcoxon rank sum test. Medians are depicted by lines. Stimulation of BAL cells with SEB resulted in a positive
IFN-g response for sarcoidosis subjects and disease controls. The p values listed are for the comparison between sarcoidosis and PPD-. No
significant difference was seen between sarcoidosis and NTM group.
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radiographic stages of sarcoidosis
We evaluated the immune responses to the multiple
antigens in terms of Scadding radiograph stage I and
II. There was no significant difference in the percen-
tage or distribution of Th-1 cellular responses
to mycobacterial antigen between these two stages
( F i g u r e7 ) .W ed i dn o ti n c l u d eS c a d d i n gs t a g e0 ,I I I ,
and IV because of the paucity of subjects with these
radiograph stages, compared to stage I and II. The
analysis was performed on diagnostic BAL, and very
few subjects presented with normal chest x-rays
(Scadding stage 0) or advanced radiographic disease
(Scadding stage III or IV).
Figure 5 Sarcoidosis CD4+ BAL T cells recognize multiple epitopes of mycobacterial proteins. BAL T cells were stimulated with a panel of
9 mycobacterial peptides and intracellular cytokine staining was performed to measure the number of IFN-g producing cells. Sarcoidosis 4, 10,
and 24 CD4+, BAL-derived T cells were stimulated with all 9 mycobacterial peptides. Not only did these subjects recognize multiple
mycobacterial peptides but also recognized multiple epitopes within the proteins. CD4+T cell response was defined as positive when the
frequency of recognition was at least twice background fluorescence and greater than 0.5%.
Figure 6 Sarcoidosis BAL T cells proliferate in response to multiple mycobacterial antigens. Sarcoidosis BAL cells were CFSE-labeled and
activated with neoantigen (KLH), ESAT-6, katG, Ag85A, sodA, and HSP. Day 4 post-activation, antigen-specific proliferation of CD4+ and CD8+
T cells was assessed by gating on CD3+CD4+ T cells or CD3+CD8+ T cells and analyzing the CFSE expression of each subset by flow cytometry.
Percent proliferation is indicated by bracket above peaks. Similar results were found in the three other tested subjects.
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The association of mycobacterial antigens with sarcoido-
sis pathogenesis continues to strengthen. Independent
studies have demonstrated molecular and immunologic
evidence of mycobacterial virulence factors in sarcoido-
sis pathogenesis [5,7]. This study is the first to report
t h ep r e s e n c eo fT h - 1i m m u n er e s p o n s e st om u l t i p l e
mycobacterial virulence factors in sarcoidosis diagnostic
bronchoalveolar lavage. This study also illustrates that
rather than a single, persistent antigen serving as the
target of the sarcoidosis adaptive immune response, this
response is heterogeneous against multiple, distinct
mycobacterial epitopes. This response is also distinct
from PPD- subjects with alternative lung diseases such
as Aspergillosis, fungal infection, and lymphoma but not
from subjects with pulmonary infection due to non-
tuberculous mycobacteria.
The observation of immune responses to these viru-
lence factors is noteworthy for several reasons. It is possi-
ble that these immune responses reflect the presence of
several persistent, poorly degradable, mycobacterial pro-
teins after prior exposure to a pathogenic Mycobacter-
ium. Previous studies in mice and humans have
demonstrated the proteins such as ESAT-6, Antigen 85
and sodA are major T cell targets of the host immune
response in humans and mice, eliciting a Th-1 immuno-
phenotype [21]. A strong immune response against these
virulence factors aid in protection against progressive
infection. Prior reports of proteins such as ESAT-6, katG
and sodA demonstrate that they are secreted through the
mycobacterial secretion system. For example, in
M. tuberculosis, the sodA protein is one of the few
proteins identified as requiring SecA2 for its secretion
[22]. It has been recently reported that it is the interac-
tion of these secreted proteins, such as ESAT-6, with
host epithelium that serve as the nidus for granuloma
formation [23].
In this study, we report Th-1 responses against multi-
ple, distinct mycobacterial antigens among sarcoidosis
subjects (Figure 5). Of the mycobacterial peptides tested,
ESAT-6 peptide was recognized most frequently by the
sarcoidosis subjects (Figure 1). This increased recogni-
tion of ESAT-6 above other mycobacterial virulence fac-
tors has been previously reported in subjects with
known mycobacterial infection [24,25]. One explanation
for the increased recognition of ESAT-6 is that it con-
tains epitopes that are recognized by a significant per-
centage of the most prevalent HLA types in the world
[26]. It should be noted that the number of subjects that
were tested using sodA and HSP was less than the num-
ber tested for other peptides due to limitations in BAL
cells. It is possible that recognition of these peptides
may have been significant if more subjects were tested.
There were also distinctions in the magnitude of the
response, as well as the number of subjects between the
sarcoidosis and PPD- subjects (Figure 1 and 2). The
magnitude of the response seen is consistent with what
has been previously reported in subjects with active
mycobacterial infection. A prior report noted the disap-
pearance of sarcoidosis responses against katG upon
clinical resolution [9], which suggests that they are
important in sarcoidosis pathogenesis. We also noted
disappearance of immune responses against katG and
ESAT-6 in three sarcoidosis subjects as they resolved
Figure 7 Presence of mycobacterial responses does not correlate with radiographic stage. Response to mycobacterial antigens was seen
in radiographic stages 1-2. There were not enough subjects with stage 3-4 to assess differences in distribution of immune recognition across
these stages. Kruskal-Wallis rank sum test was used to assess differences in distribution of immune responses. Medians depicted by lines.
(A) CD4+ T cell response to ESAT-6, katG, Ag85A, sodA, and HSP. (B) CD8+ T cell response to ESAT-6, katG, Ag85A, sodA, and HSP.
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Page 9 of 11their disease (unpublished data). Immune responses
against these mycobacterial antigens have also been
reported in subjects with infection by known virulent
mycobacteria [27,28]. The absence of immune responses
to KLH, as well as the detection of proliferation upon
stimulation by these antigens, also demonstrates that
they are targets of the sarcoidosis adaptive immune
response at the time of diagnosis (Figure 6).
Conclusions
In summary, this investigation demonstrates that
numerous epitopes of mycobacterial virulence factors
are targets of the adaptive immune response, eliciting a
Th-1 immunophenotype within CD4+ and CD8+
T cells. It is possible that other mycobacterial and
human antigens not reported in this study are also
targets of BAL-derived T cells. The magnitude of the
response mimics those that have been reported in sub-
jects with active mycobacterial infection, and warrants
further investigation of the contribution mycobacteria
have to sarcoidosis pathogenesis.
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